Clinical and Diagnostic Laboratory Immunology, September 2003, p. 741-743, Vol. 10, No. 5
1071-412X/03/$08.00+0 DOI: 10.1128/CDLI.10.5.741-743.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
High Levels of Interleukin-1 in Patients with Endemic Pemphigus Foliaceus
Denise Bertulucci Rocha-Rodrigues,1,2 Giovana Paschoini,1 Sanivia Aparecida Lima Pereira,1,2 Marlene Antonia dos Reis,1 Vicente de Paula Antunes Teixeira,1 and Virmondes Rodrigues Jr.1*
Faculdade de Medicina do Triângulo Mineiro,1
Universidade de Uberaba, Uberaba, Minas Gerais, Brazil2
Received 10 December 2002/
Returned for modification 4 February 2003/
Accepted 26 June 2003
Endemic pemphigus foliaceus (EPF) is an autoimmune disease characterized by blister formation with a loss of cohesion and infiltration of inflammatory cells. We observed that supernatants of peripheral blood mononuclear cells from patients produced significantly more interleukin-1ß (IL-1ß) than those from stimulated healthy controls. Furthermore, a Th2 bias was observed in EPF patients when the IL-5/gamma interferon ratio was analyzed. These results indicate that cells from pemphigus patients react with a vigorous proinflammatory response.
* Corresponding author. Mailing address: Faculdade de Medicina do Triângulo Mineiro, Laboratory of Immunology, 30, Frei Paulino, Uberaba, Minas Gerais 38025-180, Brazil. Phone: 55 34 3318 52 89. Fax: 55 34 3318 56 51. E-mail: vrodrigues{at}mednet.com.br.
Clinical and Diagnostic Laboratory Immunology, September 2003, p. 741-743, Vol. 10, No. 5
1071-412X/03/$08.00+0 DOI: 10.1128/CDLI.10.5.741-743.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Mashiah, J., Brenner, S.
(2005). Possible Mechanisms in the Induction of Pemphigus Foliaceus by Topical Imiquimod Treatment. Arch Dermatol
141: 908-909
[Full Text]
Copyright © 2003 by the American Society for Microbiology. All rights reserved.